You can be on Entrepreneur’s cover!

Judge Permanently Bans 'Chaotic' and 'Untrustworthy' Martin Shkreli From Running Public Companies Shkreli had asked for a 10-year officer and director restriction.

By Amanda Breen

entrepreneur daily

Infamous 'Pharma Bro' Martin Shkreli will never sit at the helm of a public company again. On Wednesday, a U.S. judge permanently banned the former pharmaceutical executive from acting as an officer or director of public companies, Reuters reports, and also fined him $1.39 million for violating securities law between 2009 and 2014.

U.S. District Judge Kiyo Matsumoto in Brooklyn issued her ruling in the Securities and Exchange Commission's civil case, alleging Shkreli swindled investors in his hedge fund and siphoned funds from his biotechnology company Retrophin to pay back those investors.

In 2015, Shkreli was the CEO of Turing Pharmaceuticals, where he gained notoriety for inflating the price of life-saving parasitic drug Daraprim overnight to $750 per tablet from $17.50. Later that year, he was arrested on fraud and conspiracy charges related to Retrophin and his MSMB Capital Management and MSMB Healthcare Management hedge funds. He was convicted of securities fraud and conspiracy in 2017 and received a seven-year sentence, which he's currently serving at a low-security prison in Allenwood, PA.

Related: 'Pharma Bro' Martin Shkreli Arrested on Securities Fraud Charges

Shkreli had asked for a 10-year officer and director restriction, claiming that his prison sentence and $7.8 million in forfeiture and fines in his associated criminal case were punishment enough. But Matsumoto called Shkreli a "chaotic, dishonest, and untrustworthy corporate leader" who would likely break the law again if given the chance to lead a public company in the future.

Last month, a federal judge in Manhattan permanently barred Shkreli from the drug industry and fined him $64.6 million.

Shkreli will be eligible for release in November of this year.

Amanda Breen

Entrepreneur Staff

Senior Features Writer

Amanda Breen is a senior features writer at Entrepreneur.com. She is a graduate of Barnard College and received an MFA in writing at Columbia University, where she was a news fellow for the School of the Arts.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Side Hustle

He Took His Side Hustle Full-Time After Being Laid Off From Meta in 2023 — Now He Earns About $200,000 a Year: 'Sweet, Sweet Irony'

When Scott Goodfriend moved from Los Angeles to New York City, he became "obsessed" with the city's culinary offerings — and saw a business opportunity.

Data & Recovery

Better Communicate Data with Your Team for $20 with Microsoft Visio

Visio features a wide range of diagramming tools that can support projects across all industries.

Growing a Business

How To Leverage Social Media to Optimize PR Success and Increase Your Brand Awareness

Entrepreneurs can establish authority and trust in their industries through the strategic use of social media, leveraging platforms for podcast appearances, guest posts, and consistent, quality content that aligns with their brand's mission.

Science & Technology

AI Will Radically Transform the Workplace — Here's How HR Teams Can Prepare for It

HR intrapreneurs are emerging as key drivers of AI reskilling, thoughtful organizational restructuring and ethical integration, shaping an inclusive future where technology enhances both efficiency and employee development.

Business News

Some Costco Stores Are Now Selling a Frozen Item That Looks Just Like a Trader Joe's Fan Favorite

The Frozen Kimbap is a Trader Joe's cult favorite, and now a version can be found at Costco, too.